Dec 29, 2023
Diabetes a Common Threat to Kids Who Survive Cancer
Kids who've survived cancer face many health challenges, and a heightened risk for diabetes is one of them, new research shows. Read...
Dec 28, 2023
Mortality Risk of Second Malignancies in Childhood Cancer Survivors
A team of researchers showed that long-term childhood cancer survivors who carry cancer-predisposing genetic variants are at an increased...
Dec 27, 2023
Bone marrow transplant increases risk of cardiovascular disease and developing insulin resistance
In a collaborative study between Fred Hutchinson Cancer Center and the University of Minnesota, Dr. Baker along with Dr. Tyler Ketterl,...
Dec 22, 2023
Unraveling predisposition in bilateral Wilms tumor
Children with bilateral Wilms tumor have a tumor in each of their kidneys — a condition that strongly suggests an underlying genetic or...
Dec 21, 2023
Rethinking the Development of CAR T-Cell Products for Pediatric Cancer
In a commentary published in the Journal of Clinical Oncology, Claudia Rossig, MD, of the department of pediatric hematology and oncology...
Dec 20, 2023
How research helped lead to FDA approval of a pediatric neuroblastoma drug
The drug, called eflornithine (DFMO) and newly branded as IWILFIN by US WorldMeds, reduces the risk of relapse for pediatric high-risk...
Dec 19, 2023
Prediabetes treatment may reduce heart and kidney risks in childhood cancer survivors
Childhood cancer survivors have a higher prevalence of prediabetes and diabetes, which increases their risk of serious disease but also...
Dec 19, 2023
'Tough kid': Borden boy to be featured in charity calendar to raise money for childhood cancer programs
A boy from CFB Borden is among a dozen kids who will be appearing in a charity calendar that will help raise funding and awareness about...
Dec 18, 2023
Dabrafenib and trametinib – a new treatment on the horizon?
Recent research suggests that there could be a new treatment on the horizon for some children diagnosed with low and high-grade gliomas....
Dec 17, 2023
Nivolumab Associated With Higher Survival in Pediatric Advanced-Stage Hodgkin Lymphoma
Replacing brentuximab vedotin with nivolumab in first-line treatment combined with the chemotherapy regimen AVD improved progression-free...